EPZ020411 hydrochloride

Research use only, not for human use.

EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM.

EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM, displays 10-fold and 20-fold selectivity over PRMT1/8, and >100-fold over other histone methyltransferases (PRMT3/4/5/7); dose-dependently decreases H3R2 methylation A375 cell line with IC50 of 0.637 uM, with no affect levels of PRMT6 expression; exhibits good bioavailability following subcutaneous dosing in rats making it a suitable tool for potential in vivo target validation studies.

EPZ020411 hydrochloride (0-20 μM; 24 h) decreases H3R2 methylation in A375 cells.EPZ020411 hydrochloride (20-40 μM; 6 h) reduces neomycin- and cisplatin-induced cell apoptosis and increases hair cell survival. Western Blot Analysis Cell Line:A375 cells Concentration:0-20 μM Incubation Time:24 hours Result:Dose-dependently decreased H3R2 methylation in A375 cells with an IC50 of 0.634 μM.Cell Viability Assay Cell Line:Cultured cochleae cells Concentration:20 and 40 μM Incubation Time:6 hours Result:Suppressed the apoptotic cascade induced by aminoglycosides and also inhibited cisplatin-induced apoptosis in the hair cells of the cochlear explants after pretreatment deposed. Reduced hair cell loss caused by cisplatin treatment.

EPZ020411 hydrochloride (10 mg/kg; i.p. once) reduces neomycin- and cisplatin-induced hearing loss in C57BL/6J wild-type mice with acute ototoxicity model.Pharmacokinetic Parameters of EPZ020411 hydrochloride in rats. Animal Model:C57BL/6J wild-type mice at P28 with acute ototoxicity model Dosage:10 mg/kg Administration:Intraperitoneal injection; 10 mg/kg once Result:Significantly reduced neomycin- and cisplatin-induced HC loss and showed no effect without neomycin injection with mice.

EPZ-020411 hydrochloride | EPZ 020411 hydrochloride

Chromatin/Epigenetic

HMTase

HMTase

Other Indications

——

2070015-25-5

479.0551

C25H39ClN4O3

>98% (HPLC)

H2O: ≥ 41 mg/mL

CNCCN(C)CC1=C(NN=C1)C2=CC=C(C=C2)OC3CC(C3)OCCC4CCOCC4.Cl

1,2-Ethanediamine, N1,N2-dimethyl-N1-[[3-[4-[[trans-3-[2-(tetrahydro-2H-pyran-4-yl)ethoxy]cyclobutyl]oxy]phenyl]-1H-pyrazol-4-yl]methyl]-,hydrochloride

(-20℃)

With Ice Pack

≥ 2 years